Emyria (ASX:EMD) EBITDA Margin %: -137.07% (As of Dec. 2025)


What is Emyria EBITDA Margin %?

Emyria ASX:EMD -2.56% EBITDA Margin % is -137.07% as of Dec. 2025. The stock has 1 warning sign investors should review. Among 668 Healthcare Providers & Services companies, Emyria ranks worse than 93.41% on this metric.

EBITDA Margin % is calculated as EBITDA divided by its Revenue. Emyria's EBITDA for the six months ended in Dec. 2025 was A$-2.13 Mil. Emyria's Revenue for the six months ended in Dec. 2025 was A$1.55 Mil. Therefore, Emyria's EBITDA margin for the quarter that ended in Dec. 2025 was -137.07%.

Emyria  (ASX:EMD) EBITDA Margin % Explanation

EBITDA Margin % is the ratio of EBITDA divided by net sales or Revenue. It is an performance metric measuring company's operating profitability. EBITDA Margin takes depreciation and amortization, interest expense and tax into account, which makes it easy to compare the relative profitability of companies of different sizes in the same industry.

Emyria EBITDA Margin % Related Terms

Emyria EBITDA Margin % Historical Data

* Premium members only.

The historical data trend for Emyria's EBITDA Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Emyria EBITDA Margin % Chart

Emyria Annual Data
Trend Jun19 Jun20 Jun21 Jun22 Jun23 Jun24 Jun25
EBITDA Margin %
Get a 7-Day Free Trial -372.10 -507.39 -289.07 -476.99 -194.19

Emyria Semi-Annual Data
Jun19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
EBITDA Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -946.15 -17.43 -92.86 -296.62 -137.07

ASX:EMD vs VEEV, BTSG, TEM: EBITDA Margin % Comparison

For the Health Information Services subindustry, Emyria's EBITDA Margin %, along with its competitors' market caps and EBITDA Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Emyria EBITDA Margin % vs Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Emyria's EBITDA Margin % distribution charts can be found below:

* The bar in red indicates where Emyria's EBITDA Margin % falls into.


Emyria EBITDA Margin % Calculation

EBITDA margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent.

Emyria's EBITDA Margin % for the fiscal year that ended in Jun. 2025 is calculated as

EBITDA Margin %=EBITDA (A: Jun. 2025 )/Revenue (A: Jun. 2025 )
=-2.542/1.309
=-194.19 %

Emyria's EBITDA Margin % for the quarter that ended in Dec. 2025 is calculated as

EBITDA Margin %=EBITDA (Q: Dec. 2025 )/Revenue (Q: Dec. 2025 )
=-2.13/1.554
=-137.07 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about EBITDA Margin % →
What does a EBITDA Margin % of -137.07% mean?
Emyria (ASX:EMD) has a EBITDA Margin % of -137.07% as of Dec. 2025. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on Emyria and its competitors. According to the industry distribution chart, Emyria ranks #624 out of 668 companies in the Healthcare Providers & Services industry, placing it in the top 93.4%.
Is Emyria's EBITDA Margin % too high?
Emyria's current EBITDA Margin % is -137.07%. Based on the distribution chart, Emyria ranks #624 out of 668 companies in the Healthcare Providers & Services industry, which is in the bottom quartile relative to peers.
How does Emyria's EBITDA Margin % compare to VEEV and BTSG?
According to the Healthcare Providers & Services industry distribution chart, Emyria ranks #624 out of 668 companies for EBITDA Margin %. This places Emyria in the lower half of its industry. The industry median EBITDA Margin % is 10.21. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBITDA Margin % for a Healthcare Providers & Services company?
The median EBITDA Margin % among Healthcare Providers & Services companies is 10.21, based on 668 companies in the industry. Companies in the top quartile (top 25%) have a EBITDA Margin % significantly above this median, while those in the bottom quartile fall well below. However, EBITDA Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBITDA Margin % mean?
A high EBITDA Margin % can signal that a stock is expensive relative to its fundamentals. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on Emyria and its competitors. For the Healthcare Providers & Services industry, the median EBITDA Margin % is 10.21 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Emyria's current EBITDA Margin % is -137.07%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Emyria stock overvalued right now?
Based on GuruFocus' analysis, Emyria (ASX:EMD) is currently considered Modestly Overvalued. The stock's GF Value™ is A$0.03, compared to a current price of A$0.04 — trading 26.7% above its estimated fair value. The current EBITDA Margin % is -137.07%. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBITDA Margin % calculated?
EBITDA Margin % is calculated from a company's financial statements. For Emyria (ASX:EMD), the current EBITDA Margin % is -137.07% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Emyria Business Description

Other Exchanges Q84:Germany
Address D2, 661 Newcastle Street, PO Box 1442, Leederville, WA, AUS, 6007
Emyria Ltd operates a network of specialist medical clinics and uses purpose-built software and technology to gather clinical data from consenting patients. It operates in one segment of research and development.